Amarnath Mukherjee
Amarnath Mukherjee
Подтвержден адрес электронной почты в домене einstein.yu.edu
Название
Процитировано
Процитировано
Год
Nucleic acid aptamers: clinical applications and promising new horizons
X Ni, M Castanares, A Mukherjee, SE Lupold
Current medicinal chemistry 18 (27), 4206-4214, 2011
3042011
Haloperidol-associated Stealth Liposomes A POTENT CARRIER FOR DELIVERING GENES TO HUMAN BREAST CANCER CELLS
A Mukherjee, TK Prasad, NM Rao, R Banerjee
Journal of Biological Chemistry 280 (16), 15619-15627, 2005
752005
Real-time, near-infrared fluorescence imaging with an optimized dye/light source/camera combination for surgical guidance of prostate cancer
BP Neuman, JB Eifler, M Castanares, WH Chowdhury, Y Chen, ...
Clinical Cancer Research 21 (4), 771-780, 2015
362015
Evaluation of prostate-specific membrane antigen as an imaging reporter
MA Castanares, A Mukherjee, WH Chowdhury, M Liu, Y Chen, RC Mease, ...
Journal of Nuclear Medicine 55 (5), 805-811, 2014
292014
Selective cancer targeting via aberrant behavior of cancer cell-associated glucocorticoid receptor
A Mukherjee, KP Narayan, K Pal, JM Kumar, N Rangaraj, SV Kalivendi, ...
Molecular Therapy 17 (4), 623-631, 2009
242009
Development and screening of a series of antibody-conjugated and silica coated iron-oxide nanoparticles for targeting the Prostate Specific Membrane Antigen
A Mukherjee, T Darlington, R Baldwin, C Holz, S Olson, P Kulkarni, ...
ChemMedChem 9 (7), 1356, 2014
202014
Systemic Administration and Targeted Radiosensitization via Chemically Synthetic Aptamer–siRNA Chimeras in Human Tumor Xenografts
X Ni, Y Zhang, K Zennami, M Castanares, A Mukherjee, RR Raval, ...
Molecular cancer therapeutics 14 (12), 2797-2804, 2015
172015
Monitoring nanoparticle-mediated cellular hyperthermia with a high-sensitivity biosensor
A Mukherjee, M Castanares, M Hedayati, M Wabler, B Trock, P Kulkarni, ...
Nanomedicine 9 (18), 2729-2743, 2014
112014
Development and application of a novel model system to study 'active' and 'passive' tumor targeting
A Mukherjee, B Kumar, K Hatano, LM Russell, BJ Trock, PC Searson, ...
Mol Cancer Ther, 2016
42016
MP87-05 UPREGULATION OF OPIORPHIN IS ASSOCIATED WITH PROSTATE CANCER; A POTENTIAL NOVEL THERAPEUTIC TARGET
A Mukherjee, L Wang, M Schoenberg, K Davies
The Journal of Urology 197 (4S), e1167-e1168, 2017
12017
Aqueous formulation for selective targeting and delivering gene to cancer cells
A Mukherjee, R Banerjee
US Patent 9,364,566, 2016
12016
Investigating the role of opiorphin genes in prostate cancer and the possible genetic mechanisms by which they modulate tumor growth and androgen-sensitivity.
A Mukherjee, A Park, L Wang, KP Davies
2020
Investigating the role of opiorphin genes in prostate cancer and the possible genetic mechanisms by which they modulate tumor growth and androgen-sensitivity
KP Davies, A Mukherjee, A Park, L Wang
2019
Identification and characterization of RSIY-11, a novel seminal peptide derived from semenogelin-1, which acts as a neutral endopeptidase inhibitor modulating sperm motility
R Fritz, A Mukherjee, S Zaghi, I Agalliu, S Jindal, AK Tashima, LD Fricker, ...
Journal of assisted reproduction and genetics 36 (9), 1891-1900, 2019
2019
PD49-08 INVESTIGATING CORPORAL GENE EXPRESSION PATTERNS IN ISCHEMIC PRIAPISM USING A BERK MOUSE MODEL
A Mukherjee, A Park, M Tar, H Billet, K Davies
The Journal of Urology 199 (4S), e968-e968, 2018
2018
RSIY-11: discovery and evaluation of a novel peptide and its relation to sperm motility
R Fritz, S Zaghi, A Mukherjee, L Fricker, I Agalliu, K Davies
Fertility and Sterility 108 (3), e39-e40, 2017
2017
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–16